Aging-associated changes in human brain

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 12, 1997, Pages 1269-1275

  Mrak, Robert E ^a,b   Griffin, W Sue T ^a,b,c   Graham, David I ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Aging; Dendritic complexity; Glial changes; Lipofuscin; Neurofibrillary tangles; Neuronal loss

Indexed keywords

ASPARTIC ACID; CHOLINE ACETYLTRANSFERASE; DNA; DOPAMINE; GLUTAMIC ACID; HYALIN; LIPOFUSCIN; NEUROTRANSMITTER; SEROTONIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN BLOOD VESSEL; BRAIN DISEASE; CELL LOSS; DENDRITE; DNA DAMAGE; GLIA CELL; HUMAN; HYPERTENSION; LEUKOARAIOSIS; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; WHITE MATTER;

EID: 0031439690     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199712000-00001     Document Type: Review

References (60)

1. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 1987;21:530-39
2. Bigl V, Arendt T, Fischer S, Werner M, Arendt A. The cholinergic system in aging. Gerontology 1987;33:172-80
3. Hall TC, Miller AKH, Corsellis JAN. Variations in human Purkinje cell populations according to age and sex. Neuropathol Appl Neurobiol 1975;1:217-92
4. Lucassen PJ, Ravid R, Gonatas NK, Swaab DF. Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res 1993;632:105-13
5. Hofman MA, Swaab DF. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol Aging 1995;16:965-71
6. Lintl P, Braak H. Loss of intracortical myelinated fibers: A distinctive age-related alteration in the human striate area. Acta Neuropathol 1983;61:178-82
7. Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994;51:477-84
8. Nakamura S, Akiguchi I, Kameyama M, Mizuno N. Age-related changes of pyramidal cell basal dendrites in layers III and V of human motor cortex: A quantitative Golgi study. Acta Neuropathol 1985;65:281-84
9. Gibson PH. E.M. study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia. Acta Neuropathol (Berl) 1983;62:127-33
10. Buell SJ, Coleman PD. Dendritic growth in the aged brain and failure of growth in senile dementia. Science 1979;206:854-56
11. Flood DG, Buell SJ, Defiore CH, Horwitz GJ, Coleman PD. Age-related dendritic growth in dentate gyrus of human brain is followed by regression in the 'oldest old.' Brain Res 1985;345:366-68
12. Ma XY, Su YB, Zhang FR, Li JF . Effects of vitamin E on the blastogenic response of splenocytes and lipofuscin contents in the hearts and brains of aged mice. J Environ Pathol Toxicol Oncol 1996;15:51-53
13. Braak H. Spindle-shaped appendages of IIIab-pyramids filled with lipofuscin: A striking pathological change of the senescent human isocortex. Acta Neuropathol 1979;46:197-202
14. Moore WA, Davey VA, Weindruch R, Walford R, Ivy GO . The effect of caloric restriction on lipofuscin accumulation in mouse brain with age. Gerontology 1995;41(Suppl 2):173-85
15. Mydlarski MB, Liberman A, Schipper HM Estrogen induction of glial heat shock proteins: Implications for hypothalamic aging. Neurobiol Aging 1995;16:977-81
16. Hof PR, Giannakopoulos P, Bouras C. The neuropathological changes associated with normal brain aging. Histol Histopathol 1996;11:1075-88
17. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH. Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiol Aging 1996;17:365-71
18. Dickson DW, Crystal HA. Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-89
19. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19
20. Mackenzie IR. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol 1994;87:520-25
21. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Ageing 1980;9:1-8
22. Alien SJ, Benton JS, Goodhardt MJ, et al. Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. J Neurochem 1983;41:256-65
23. Zelnik N, Angel I, Paul SM, Kleinman JE. Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 1986;126:175-76
24. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA 1992; 89:7095-99
25. Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease. J Neurochem 1992;58:642-48
26. Kalaria RN, Andorn AC, Harik SI. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging. Prog Clin Biol Res 1989;317:367-74
27. Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR. Adrenergic receptors in aging and Alzheimer's disease: Increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem 1989;53:1772-81
28. Banay-Schwartz M, Lajtha A, Palkovits M, Nathan S. Regional distribution of glutamate and aspartate in adult and old human brain. Brain Res 1992;594:343-46
29. Spangler KM, Challa VR, Moody DM, Bell MA. Arteriolar tortuosity of the white matter in aging and hypertension. A microradiographic study. J Neuropathol Exp Neurol 1994;53:22-26
30. Dozono K, Ishii N, Nishihara Y, Horie A. An autopsy study of the incidence of lacunes in relation to age, hypertension, and arterio-sclerosis. Stroke 1991;22:993-96
31. Fushimi H, Inoue T, Yamada Y, Udaka F, Kameyama M. Asymptomatic lacunes and their relationship to intellectual disturbances. Internal Med 1994;33:317-20
32. Steingart A, Hachinski VC, Lau C, et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987; 44:36-39
33. Almkvist O, Wahlund LO. Andersson-Lundman G. Basun H. Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-32
34. Inzitari D, Diaz F, Fox A, et al. Vascular risk factors and leukoaraiosis. Archiv Neurol 1987;44:42-47
35. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995;26:1293-1301
36. Rezek DL, Morris JC, Fulling KH, Gado MH. Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology 1987;37:1365-68
37. Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: Association with leukoaraiosis. Radiology 1995;194:469-76
38. Wong KT, Grossman RI, Boorstein JM, Lexa FJ, McGowan JC. Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. Am J Neuroradiol 1995;16:253-58
39. Hansen LA, Armstrong DM, Terry RD. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol Aging 1987;8:1-6
40. Mrak RE, Sheng JG, Griffin WST: Correlation of astrocytic S100β expression with dystrophic neuntes in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:273-79
41. Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST: Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol Aging 1996;17:359-63
42. + microglia increase with age in normal human brain. Acta Neuropathol (Berl) Forthcoming.
43. Mrak RE, Sheng JG, Griffin WST: Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Hum Pathol 1995;26: 816-23
44. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen SH. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 1990;63:87-99
45. Iseki E, Odawara T, Li F, et al. Age-related ubiquitin-positive granular structures in non-demented subjects and neurodegenerative disorders. J Neurol Sci 1996;142:25-29
46. Gertz HJ, Cervos-Navarro J, Frydl V, Schultz F. Glycogen accumulation of the aging human brain. Mech Ageing Dev 1985;31: 25-35
47. Smith CD, Carney JM, Starke-Reed PE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 1991;88:10540-43
48. Stadtman ER, Starke-Reed PE, Oliver CN, Carney JM, Floyd RA. Protein modification in aging. EXS 1992;62:64-72
49. Mandavilli BS, Rao KS. Neurons in the cerebral cortex are most susceptible to DNA-damage in aging rat brain. Biochem Mol Biol Int 1996;40:507-14
50. Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34:609-16
51. Kapsa RM, Jean-Francois MJ, Lertrit P, et al. Mitochondrial DNA polymorphism in substantia nigra. J Neurol Sci 1996;144:204-11
52. Munch G, Thome J, Foley P, Schinzel R, Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Rev 1997;23:134-43
53. Vlassara H, Brownlee M, Cerami A. Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging. Prog Clin Biol Res 1989;304:205-18
54. Ogeng'o JA, Cohen DL, Sayi JG, et al. Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Brain Pathol 1996;6:101-7
55. Ng HK, Lee JC. Degenerative cerebral alterations in Chinese aged 65 years or older. Clin Neuropathol 1988;7:280-84
56. Yue NC, Arnold AM, Longstreth WT Jr, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: Data from the cardiovascular health study. Radiology 1997;202:33-39
57. Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993;24(12 Suppl):I16-19
58. Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: Normative database spanning 5 decades of life. Amer J Neuroradiol 1995;16:241-51
59. Golomb J, de Leon MJ, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol 1993;50:967-73
60. Hofman MA, Fliers E, Goudsmit E, Swaab DF. Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: Sex differences and age-dependent changes. J Anat 1988; 160:127-43